Zydus Lifesciences informs about press release

23 Mar 2024 Evaluate
Zydus Lifesciences has informed that a press release dated March 23, 2024 titled ‘Zydus receives tentative approval from USFDA for Letermovir Tablets, 240 mg and 480 mg’ is enclosed.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1104.45 52.55 (5.00%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.